Literature DB >> 18408179

Size overlap between benign melanocytic choroidal nevi and choroidal malignant melanomas.

James J Augsburger1, Zélia M Corrêa, Nikolaos Trichopoulos, Adeel Shaikh.   

Abstract

PURPOSE: To estimate size overlap between large choroidal nevi and small choroidal melanomas by using plotted frequency distributions of tumor size.
METHODS: Frequency distributions of largest linear basal diameter (LBD) and thickness (TH) of choroidal nevi and melanomas were plotted from published data and cases in the senior author's practice. Relative frequencies of choroidal nevi and melanomas were estimated from published data. Relative frequency distributions of the tumors were plotted to illustrate the extent of overlap between them.
RESULTS: Comparison of plotted frequency distribution curves for thickness indicated that there were approximately 125 nevi for every melanoma in the TH range 1.5 to 2 mm, approximately 25 nevi for every melanoma in the TH range 2 to 2.5 mm, and approximately 5 nevi for every melanoma in the TH range 2.5 to 3 mm. Similarly, comparison of the plotted frequency distribution curves for LBD of these tumor types indicated that there were approximately 70 nevi for every choroidal melanoma in the LBD range 5 to 6 mm, approximately 10 nevi for every melanoma in the LBD range 6 to 7 mm, and approximately 3 nevi for every melanoma in the LBD range 7 to 8 mm.
CONCLUSIONS: Because of the markedly greater cumulative lifetime incidence of choroidal nevi, the results of this analysis suggest considerable size overlap between larger nevi and smaller melanomas. Attempts to classify small melanocytic choroidal tumors clinically as benign nevi versus malignant melanomas on the basis of tumor size appear likely to result in multiple misclassifications.

Entities:  

Mesh:

Year:  2008        PMID: 18408179     DOI: 10.1167/iovs.07-1603

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Are Risk Factors for Growth of Choroidal Nevi Associated With Malignant Transformation? Assessment With a Validated Genomic Biomarker.

Authors:  J William Harbour; Manuel Paez-Escamilla; Louis Cai; Scott D Walter; James J Augsburger; Zelia M Correa
Journal:  Am J Ophthalmol       Date:  2018-09-07       Impact factor: 5.258

2.  What's in a Name? Large Choroidal Nevus, Small Choroidal Melanoma, or Indeterminate Melanocytic Tumor.

Authors:  Arun D Singh; Hans E Grossniklaus
Journal:  Ocul Oncol Pathol       Date:  2021-06-07

3.  Choroidal pigmented lesions imaged by ultra-wide-field scanning laser ophthalmoscopy with two laser wavelengths (Optomap).

Authors:  Marcus Kernt; Ulrich C Schaller; Carmen Stumpf; Michael W Ulbig; Anselm Kampik; Aljoscha S Neubauer
Journal:  Clin Ophthalmol       Date:  2010-07-30

4.  Role of wide-field autofluorescence imaging and scanning laser ophthalmoscopy in differentiation of choroidal pigmented lesions.

Authors:  Lukas Reznicek; Carmen Stumpf; Florian Seidensticker; Anselm Kampik; Aljoscha S Neubauer; Marcus Kernt
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

5.  A pilot study to image the vascular network of small melanocytic choroidal tumors with speckle noise-free 1050-nm swept source optical coherence tomography (OCT choroidal angiography).

Authors:  Peter Maloca; Cyrill Gyger; Pascal W Hasler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-04       Impact factor: 3.117

6.  Atypical choroidal nevus in a subject with a germline PALB2 pathogenic variant.

Authors:  Timothy W Grosel; Matthew Karl; Robert T Pilarski; Frederick H Davidorf; Mohamed H Abdel-Rahman; Colleen M Cebulla
Journal:  Fam Cancer       Date:  2021-01-06       Impact factor: 2.375

7.  Distinguishing Choroidal Nevi from Melanomas Using the MOLES Algorithm: Evaluation in an Ocular Nevus Clinic.

Authors:  Lamis Al Harby; Mandeep S Sagoo; Roderick O'Day; Gordon Hay; Amit K Arora; Pearse A Keane; Victoria M-L Cohen; Bertil Damato
Journal:  Ocul Oncol Pathol       Date:  2021-03-15

8.  The MOLES System for Planning Management of Melanocytic Choroidal Tumors: Is It Safe?

Authors:  Kelsey A Roelofs; Roderick O'Day; Lamis Al Harby; Amit K Arora; Victoria M L Cohen; Mandeep S Sagoo; Bertil Damato
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

9.  Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma.

Authors:  Prisca Bustamante; Thupten Tsering; Jacqueline Coblentz; Christina Mastromonaco; Mohamed Abdouh; Cristina Fonseca; Rita P Proença; Nadya Blanchard; Claude Laure Dugé; Rafaella Atherino Schmidt Andujar; Emma Youhnovska; Miguel N Burnier; Sonia A Callejo; Julia V Burnier
Journal:  J Exp Clin Cancer Res       Date:  2021-06-16

10.  Identification of prognostic genes in uveal melanoma microenvironment.

Authors:  Huan Luo; Chao Ma
Journal:  PLoS One       Date:  2020-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.